APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Drug Delivery System

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Selected research

Market Structure

Global Transdermal Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17389565039 January 2026192 pages

Choose your research edition.

Industry ResearchTransdermal Drug Delivery System Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Drug Delivery System Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Transdermal Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Drug Delivery System Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Drug Delivery System Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.

In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.

Read the full market overview

Report Includes

This report provides an overview of the global Transdermal Drug Delivery System market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Drug Delivery System and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Drug Delivery System revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Transdermal Drug Delivery System market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Drug Delivery System Segment by Company

Hisamitsu

Mylan

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

Teikoku Seiyaku

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

Transdermal Drug Delivery System Segment by Type

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Other

Transdermal Drug Delivery System Segment by Application

OTC

Rx

Transdermal Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Transdermal Drug Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Drug Delivery System industry.

Chapter 3: Detailed analysis of Transdermal Drug Delivery System companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Drug Delivery Systemrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Fentanyl Table 3. Key Players of Nitroglycerin Table 4. Key Players of Estradiol Table 3. Key Players of Nicotine Table 4. Key Players of Other Table 5. Global Transdermal Drug Delivery System Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of OTC Table 7. Key Players of Rx Table 8. Global Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Transdermal Drug Delivery System Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Transdermal Drug Delivery System Market Share by Region (2021-2026) Table 11. Global Transdermal Drug Delivery System Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Transdermal Drug Delivery System Market Share by Region (2027-2032) Table 13. Transdermal Drug Delivery System Industry Trends Table 14. Transdermal Drug Delivery System Industry Drivers Table 15. Transdermal Drug Delivery System Industry Opportunities and Challenges Table 16. Transdermal Drug Delivery System Industry Restraints Table 17. Global Transdermal Drug Delivery System Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Transdermal Drug Delivery System Revenue Market Share by Company (2021-2026) Table 19. Global Transdermal Drug Delivery System Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Transdermal Drug Delivery System Key Company Head Office and Area Served Table 21. Global Transdermal Drug Delivery System Company, Product Type & Application Table 22. Global Transdermal Drug Delivery System Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Transdermal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Transdermal Drug Delivery System Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Transdermal Drug Delivery System Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Transdermal Drug Delivery System Revenue Market Share by Type (2021-2026) Table 29. Global Transdermal Drug Delivery System Revenue Market Share by Type (2027-2032) Table 30. Global Transdermal Drug Delivery System Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Transdermal Drug Delivery System Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Transdermal Drug Delivery System Revenue Market Share by Application (2021-2026) Table 34. Global Transdermal Drug Delivery System Revenue Market Share by Application (2027-2032) Table 35. Hisamitsu Company Information Table 36. Hisamitsu Business Overview Table 37. Hisamitsu Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Hisamitsu Transdermal Drug Delivery System Product Portfolio Table 39. Hisamitsu Recent Development Table 40. Mylan Company Information Table 41. Mylan Business Overview Table 42. Mylan Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Mylan Transdermal Drug Delivery System Product Portfolio Table 44. Mylan Recent Development Table 45. GSK Company Information Table 46. GSK Business Overview Table 47. GSK Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. GSK Transdermal Drug Delivery System Product Portfolio Table 49. GSK Recent Development Table 50. Novartis Company Information Table 51. Novartis Business Overview Table 52. Novartis Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novartis Transdermal Drug Delivery System Product Portfolio Table 54. Novartis Recent Development Table 55. Teve (Actavis) Company Information Table 56. Teve (Actavis) Business Overview Table 57. Teve (Actavis) Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Teve (Actavis) Transdermal Drug Delivery System Product Portfolio Table 59. Teve (Actavis) Recent Development Table 60. Johnson & Johnson Company Information Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Johnson & Johnson Transdermal Drug Delivery System Product Portfolio Table 64. Johnson & Johnson Recent Development Table 65. Lohmann Company Information Table 66. Lohmann Business Overview Table 67. Lohmann Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lohmann Transdermal Drug Delivery System Product Portfolio Table 69. Lohmann Recent Development Table 70. Teikoku Seiyaku Company Information Table 71. Teikoku Seiyaku Business Overview Table 72. Teikoku Seiyaku Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio Table 74. Teikoku Seiyaku Recent Development Table 75. Bayer Company Information Table 76. Bayer Business Overview Table 77. Bayer Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Bayer Transdermal Drug Delivery System Product Portfolio Table 79. Bayer Recent Development Table 80. Lingrui Company Information Table 81. Lingrui Business Overview Table 82. Lingrui Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Lingrui Transdermal Drug Delivery System Product Portfolio Table 84. Lingrui Recent Development Table 85. Sanofi Company Information Table 86. Sanofi Business Overview Table 87. Sanofi Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Sanofi Transdermal Drug Delivery System Product Portfolio Table 89. Sanofi Recent Development Table 90. Qizheng Company Information Table 91. Qizheng Business Overview Table 92. Qizheng Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Qizheng Transdermal Drug Delivery System Product Portfolio Table 94. Qizheng Recent Development Table 95. Endo Company Information Table 96. Endo Business Overview Table 97. Endo Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Endo Transdermal Drug Delivery System Product Portfolio Table 99. Endo Recent Development Table 100. Huarun 999 Company Information Table 101. Huarun 999 Business Overview Table 102. Huarun 999 Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Huarun 999 Transdermal Drug Delivery System Product Portfolio Table 104. Huarun 999 Recent Development Table 105. Haw Par Company Information Table 106. Haw Par Business Overview Table 107. Haw Par Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Haw Par Transdermal Drug Delivery System Product Portfolio Table 109. Haw Par Recent Development Table 110. Nichiban Company Information Table 111. Nichiban Business Overview Table 112. Nichiban Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Nichiban Transdermal Drug Delivery System Product Portfolio Table 114. Nichiban Recent Development Table 115. Mentholatum Company Information Table 116. Mentholatum Business Overview Table 117. Mentholatum Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Mentholatum Transdermal Drug Delivery System Product Portfolio Table 119. Mentholatum Recent Development Table 120. Laboratoires Genevrier Company Information Table 121. Laboratoires Genevrier Business Overview Table 122. Laboratoires Genevrier Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio Table 124. Laboratoires Genevrier Recent Development Table 125. North America Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million) Table 126. North America Transdermal Drug Delivery System Market Size by Type (2027-2032) & (US$ Million) Table 127. North America Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million) Table 128. North America Transdermal Drug Delivery System Market Size by Application (2027-2032) & (US$ Million) Table 129. North America Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Transdermal Drug Delivery System Market Size by Country (2021-2026) Table 131. North America Transdermal Drug Delivery System Market Size by Country (2027-2032) Table 132. Europe Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe Transdermal Drug Delivery System Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe Transdermal Drug Delivery System Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Transdermal Drug Delivery System Market Size by Country (2021-2026) Table 138. Europe Transdermal Drug Delivery System Market Size by Country (2027-2032) Table 139. China Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million) Table 140. China Transdermal Drug Delivery System Market Size by Type (2027-2032) & (US$ Million) Table 141. China Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million) Table 142. China Transdermal Drug Delivery System Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia Transdermal Drug Delivery System Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia Transdermal Drug Delivery System Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Transdermal Drug Delivery System Market Size by Country (2021-2026) Table 149. Asia Transdermal Drug Delivery System Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Transdermal Drug Delivery System Product Image Figure 2. Global Transdermal Drug Delivery System Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Transdermal Drug Delivery System Market Share by Type: 2025 VS 2032 Figure 4. Fentanyl Image Figure 5. Nitroglycerin Image Figure 6. Estradiol Image Figure 7. Nicotine Image Figure 8. Other Image Figure 9. Global Transdermal Drug Delivery System Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Transdermal Drug Delivery System Market Share by Application: 2025 VS 2032 Figure 11. OTC Image Figure 12. Rx Image Figure 13. Global Transdermal Drug Delivery System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 15. Global Transdermal Drug Delivery System Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Transdermal Drug Delivery System Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Transdermal Drug Delivery System Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Transdermal Drug Delivery System Revenue Market Share by Type (2021-2032) Figure 22. Global Transdermal Drug Delivery System Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Transdermal Drug Delivery System Revenue Market Share by Application (2021-2032) Figure 24. North America Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 25. North America Transdermal Drug Delivery System Market Share by Type (2021-2032) Figure 26. North America Transdermal Drug Delivery System Market Share by Application (2021-2032) Figure 27. North America Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 28. United States Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 29. Canada Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 31. Europe Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 32. Europe Transdermal Drug Delivery System Market Share by Type (2021-2032) Figure 33. Europe Transdermal Drug Delivery System Market Share by Application (2021-2032) Figure 34. Europe Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 35. Germany Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 36. France Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 38. Italy Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 39. Russia Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 41. China Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 42. China Transdermal Drug Delivery System Market Share by Type (2021-2032) Figure 43. China Transdermal Drug Delivery System Market Share by Application (2021-2032) Figure 44. Asia Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 45. Asia Transdermal Drug Delivery System Market Share by Type (2021-2032) Figure 46. Asia Transdermal Drug Delivery System Market Share by Application (2021-2032) Figure 47. Asia Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 48. Japan Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 52. India Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 53. Australia Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Transdermal Drug Delivery System Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Transdermal Drug Delivery System Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2021-2032) Figure 58. Brazil Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 63. UAE Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 65. Chile Transdermal Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl
  • Nitroglycerin
  • Estradiol
  • Nicotine
  • Other
Applications
  • OTC
  • Rx
Companies covered
  • Hisamitsu
  • Mylan
  • GSK
  • Novartis
  • Teve (Actavis)
  • Johnson & Johnson
  • Lohmann
  • Teikoku Seiyaku
  • Bayer
  • Lingrui
  • Sanofi
  • Qizheng
  • Endo
  • Huarun 999
  • Haw Par
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Fentanyl
  5. 1.2.3 Nitroglycerin
  6. 1.2.4 Estradiol
  7. 1.2.5 Nicotine
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 OTC
  12. 1.3.3 Rx
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Transdermal Drug Delivery System Growth Trends by Region
  15. 1.5.1 Global Transdermal Drug Delivery System Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Transdermal Drug Delivery System Market Size by Region (2021-2026)
  17. 1.5.3 Transdermal Drug Delivery System Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Transdermal Drug Delivery System Market Dynamics
  1. 2.1 Transdermal Drug Delivery System Industry Trends
  2. 2.2 Transdermal Drug Delivery System Industry Drivers
  3. 2.3 Transdermal Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Transdermal Drug Delivery System Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Transdermal Drug Delivery System Revenue by Company (2021-2026)
  2. 3.2 Global Transdermal Drug Delivery System Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Transdermal Drug Delivery System Key Company Head office and Area Served
  4. 3.4 Global Transdermal Drug Delivery System Company, Product Type & Application
  5. 3.5 Global Transdermal Drug Delivery System Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Transdermal Drug Delivery System Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Transdermal Drug Delivery System Tier 1, Tier 2, and Tier 3
4 Transdermal Drug Delivery System Market by Type
  1. 4.1 Global Transdermal Drug Delivery System Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Transdermal Drug Delivery System Market Size by Type (2021-2032)
  3. 4.3 Global Transdermal Drug Delivery System Market Size Share by Type (2021-2032)
5 Transdermal Drug Delivery System Market by Application
  1. 5.1 Global Transdermal Drug Delivery System Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Transdermal Drug Delivery System Market Size by Application (2021-2032)
  3. 5.3 Global Transdermal Drug Delivery System Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Hisamitsu
  2. 6.1.1 Hisamitsu Company Information
  3. 6.1.2 Hisamitsu Business Overview
  4. 6.1.3 Hisamitsu Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
  6. 6.1.5 Hisamitsu Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GSK Transdermal Drug Delivery System Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Teve (Actavis)
  26. 6.5.1 Teve (Actavis) Company Information
  27. 6.5.2 Teve (Actavis) Business Overview
  28. 6.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
  30. 6.5.5 Teve (Actavis) Recent Developments
  31. 6.6 Johnson & Johnson
  32. 6.6.1 Johnson & Johnson Company Information
  33. 6.6.2 Johnson & Johnson Business Overview
  34. 6.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
  36. 6.6.5 Johnson & Johnson Recent Developments
  37. 6.7 Lohmann
  38. 6.7.1 Lohmann Company Information
  39. 6.7.2 Lohmann Business Overview
  40. 6.7.3 Lohmann Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
  42. 6.7.5 Lohmann Recent Developments
  43. 6.8 Teikoku Seiyaku
  44. 6.8.1 Teikoku Seiyaku Company Information
  45. 6.8.2 Teikoku Seiyaku Business Overview
  46. 6.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
  48. 6.8.5 Teikoku Seiyaku Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 Lingrui
  56. 6.10.1 Lingrui Company Information
  57. 6.10.2 Lingrui Business Overview
  58. 6.10.3 Lingrui Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
  60. 6.10.5 Lingrui Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
  67. 6.12 Qizheng
  68. 6.12.1 Qizheng Company Information
  69. 6.12.2 Qizheng Business Overview
  70. 6.12.3 Qizheng Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
  72. 6.12.5 Qizheng Recent Developments
  73. 6.13 Endo
  74. 6.13.1 Endo Company Information
  75. 6.13.2 Endo Business Overview
  76. 6.13.3 Endo Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Endo Transdermal Drug Delivery System Product Portfolio
  78. 6.13.5 Endo Recent Developments
  79. 6.14 Huarun 999
  80. 6.14.1 Huarun 999 Company Information
  81. 6.14.2 Huarun 999 Business Overview
  82. 6.14.3 Huarun 999 Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
  84. 6.14.5 Huarun 999 Recent Developments
  85. 6.15 Haw Par
  86. 6.15.1 Haw Par Company Information
  87. 6.15.2 Haw Par Business Overview
  88. 6.15.3 Haw Par Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
  90. 6.15.5 Haw Par Recent Developments
  91. 6.16 Nichiban
  92. 6.16.1 Nichiban Company Information
  93. 6.16.2 Nichiban Business Overview
  94. 6.16.3 Nichiban Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
  96. 6.16.5 Nichiban Recent Developments
  97. 6.17 Mentholatum
  98. 6.17.1 Mentholatum Company Information
  99. 6.17.2 Mentholatum Business Overview
  100. 6.17.3 Mentholatum Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
  102. 6.17.5 Mentholatum Recent Developments
  103. 6.18 Laboratoires Genevrier
  104. 6.18.1 Laboratoires Genevrier Company Information
  105. 6.18.2 Laboratoires Genevrier Business Overview
  106. 6.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
  108. 6.18.5 Laboratoires Genevrier Recent Developments
7 North America
  1. 7.1 North America Transdermal Drug Delivery System Market Size (2021-2032)
  2. 7.2 North America Transdermal Drug Delivery System Market Size by Type
  3. 7.2.1 North America Transdermal Drug Delivery System Market Size by Type (2021-2026)
  4. 7.2.2 North America Transdermal Drug Delivery System Market Size by Type (2027-2032)
  5. 7.2.3 North America Transdermal Drug Delivery System Market Share by Type (2021-2032)
  6. 7.3 North America Transdermal Drug Delivery System Market Size by Application
  7. 7.3.1 North America Transdermal Drug Delivery System Market Size by Application (2021-2026)
  8. 7.3.2 North America Transdermal Drug Delivery System Market Size by Application (2027-2032)
  9. 7.3.3 North America Transdermal Drug Delivery System Market Share by Application (2021-2032)
  10. 7.4 North America Transdermal Drug Delivery System Market Size by Country
  11. 7.4.1 North America Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Transdermal Drug Delivery System Market Size by Country (2021-2026)
  13. 7.4.3 North America Transdermal Drug Delivery System Market Size by Country (2027-2032)
  14. 7.4.4 North America Transdermal Drug Delivery System Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Transdermal Drug Delivery System Market Size (2021-2032)
  2. 8.2 Europe Transdermal Drug Delivery System Market Size by Type
  3. 8.2.1 Europe Transdermal Drug Delivery System Market Size by Type (2021-2026)
  4. 8.2.2 Europe Transdermal Drug Delivery System Market Size by Type (2027-2032)
  5. 8.2.3 Europe Transdermal Drug Delivery System Market Share by Type (2021-2032)
  6. 8.3 Europe Transdermal Drug Delivery System Market Size by Application
  7. 8.3.1 Europe Transdermal Drug Delivery System Market Size by Application (2021-2026)
  8. 8.3.2 Europe Transdermal Drug Delivery System Market Size by Application (2027-2032)
  9. 8.3.3 Europe Transdermal Drug Delivery System Market Share by Application (2021-2032)
  10. 8.4 Europe Transdermal Drug Delivery System Market Size by Country
  11. 8.4.1 Europe Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Transdermal Drug Delivery System Market Size by Country (2021-2026)
  13. 8.4.3 Europe Transdermal Drug Delivery System Market Size by Country (2027-2032)
  14. 8.4.4 Europe Transdermal Drug Delivery System Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Transdermal Drug Delivery System Market Size (2021-2032)
  2. 9.2 China Transdermal Drug Delivery System Market Size by Type
  3. 9.2.1 China Transdermal Drug Delivery System Market Size by Type (2021-2026)
  4. 9.2.2 China Transdermal Drug Delivery System Market Size by Type (2027-2032)
  5. 9.2.3 China Transdermal Drug Delivery System Market Share by Type (2021-2032)
  6. 9.3 China Transdermal Drug Delivery System Market Size by Application
  7. 9.3.1 China Transdermal Drug Delivery System Market Size by Application (2021-2026)
  8. 9.3.2 China Transdermal Drug Delivery System Market Size by Application (2027-2032)
  9. 9.3.3 China Transdermal Drug Delivery System Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Transdermal Drug Delivery System Market Size (2021-2032)
  2. 10.2 Asia Transdermal Drug Delivery System Market Size by Type
  3. 10.2.1 Asia Transdermal Drug Delivery System Market Size by Type (2021-2026)
  4. 10.2.2 Asia Transdermal Drug Delivery System Market Size by Type (2027-2032)
  5. 10.2.3 Asia Transdermal Drug Delivery System Market Share by Type (2021-2032)
  6. 10.3 Asia Transdermal Drug Delivery System Market Size by Application
  7. 10.3.1 Asia Transdermal Drug Delivery System Market Size by Application (2021-2026)
  8. 10.3.2 Asia Transdermal Drug Delivery System Market Size by Application (2027-2032)
  9. 10.3.3 Asia Transdermal Drug Delivery System Market Share by Application (2021-2032)
  10. 10.4 Asia Transdermal Drug Delivery System Market Size by Country
  11. 10.4.1 Asia Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Transdermal Drug Delivery System Market Size by Country (2021-2026)
  13. 10.4.3 Asia Transdermal Drug Delivery System Market Size by Country (2027-2032)
  14. 10.4.4 Asia Transdermal Drug Delivery System Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Transdermal Drug Delivery System Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Transdermal Drug Delivery System Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Transdermal Drug Delivery System Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst